EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Integrative Approaches to Treating Cellular Senescence in Kidney Disease

Tomoka Misawa iD, Amruta A iD, LaTonya J Hickson iD, Joy Wolfram iD

Advanced Science · 2026-04 · 13 (21)

DOI: 10.1002/advs.202519392 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 14.03.2026. Verfasst von Tomoka Misawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, The University of Queensland, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Cellular Senescence, Kidney Diseases, Senotherapeutics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 292 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, United States under Award No..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence in the kidney plays a crucial role in the progression of acute kidney injury and chronic kidney disease. Therapeutic approaches targeting senescent cells, such as small molecule senolytic and senomorphic drugs, display efficacy in preclinical models. However, such drugs pose a risk of adverse effects and only partially mitigate disease progression, highlighting the need for new therapeutic approaches that more comprehensively and safely address disease pathways in aging kidney disease. This review discusses the potential of extracellular vesicles and longevity proteins, such as α‐klotho and silencing information regulator 2‐related enzyme 1 (SIRT1), in regulating cellular senescence and alleviating kidney fibrosis. Particularly, combination therapy that simultaneously targets inflammation, tissue damage, and senescence is promising for kidney disease, given the potential to synergistically overcome the limitations of current unimodular treatment modalities and pave the way for more effective management of kidney disease. This review highlights the mechanisms of cellular senescence in kidney disease, particularly in diabetic kidney disease, the latest knowledge on senotherapy, and the potential and challenges of new therapeutic strategies, including combining extracellular vesicles and longevity proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceKidney DiseasesSenotherapeuticsHumansExtracellular VesiclesAnimals

Stichwörter der Autor:innen

cellular senescencecombination therapyextracellular vesiclekidney diseaselongevity proteinmesenchymal stem cell

Substanzen

Senotherapeutics

Autor:innen und Institutionen

  • School of Chemical Engineering, The University of Queensland, Brisbane, Queensland, Australia.
  • School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore.
  • Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Jacksonville, Florida, USA.
  • Center For Regenerative Biotherapeutics, Mayo Clinic, Jacksonville, Florida, USA.
  • Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.

ORCID-Profile: Tomoka Misawa, Amruta A, LaTonya J Hickson, Joy Wolfram

Förderung

  • National Institutes of Health, United States under Award No.

Zitieren

APA

Misawa, T., A, A., Hickson, L. J., & Wolfram, J. (2026). Integrative Approaches to Treating Cellular Senescence in Kidney Disease. Advanced Science, 13(21). https://doi.org/10.1002/advs.202519392

Vancouver

Misawa T, A A, Hickson LJ, Wolfram J. Integrative Approaches to Treating Cellular Senescence in Kidney Disease. Advanced Science. 2026;13(21). doi:10.1002/advs.202519392

BibTeX
@article{Misawa2026,
  author = {Misawa, Tomoka and A, Amruta and Hickson, LaTonya J and Wolfram, Joy},
  title = {Integrative Approaches to Treating Cellular Senescence in Kidney Disease},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {21},
  doi = {10.1002/advs.202519392}
}
Kostenlos starten →